Brain-derived neurotrophic factor concentration may not be depressed in CFS

Research abstract:

Due to its effect on the central nervous system, brain-derived neurotrophic factor (BDNF) has been hypothesized to be involved in a number of neurodegenerative and psychiatric disorders. Recently, BDNF was also reported to be significantly lower in patients with chronic fatigue syndrome (CFS) and multiple sclerosis patients, than in healthy controls.

We tried to repeat this observation in 25 patients with CFS matched to 25 healthy controls and 11 patients with systemic lupus erythematosus. Our study did not find significant differences in BDNF between groups.

Furthermore, we investigated the relationship between BDNF levels and fatigue within CFS sufferers using the fatigue severity score and found no correlation between the two measures.

Our findings act as a caution that results should be replicated in independent laboratories for validation, and we would welcome more research in this area.

Brain-derived neurotrophic factor concentration may not be depressed in chronic fatigue syndrome, by David M. Patrick, Ruth R. Miller, Theodore Steiner, Jennifer L. Gardy, Shoshana M. Parker & Patrick Tang in Fatigue: Biomedicine, Health & Behavior, 27 March 2015 [e-published before print]

Posted in News | Tagged , , , | Comments Off on Brain-derived neurotrophic factor concentration may not be depressed in CFS

Computer simulation explores cause for exercise intolerance in ME/CFS

Research abstract:

Post-exertional malaise is commonly observed in patients with myalgic encephalomyelitis/chronic fatigue syndrome, but its mechanism is not yet well understood.

A reduced capacity for mitochondrial ATP synthesis is associated with the pathogenesis of CFS and is suspected to be a major contribution to exercise intolerance in CFS patients.

To demonstrate the connection between a reduced mitochondrial capacity and exercise intolerance, we present a model which simulates metabolite dynamics in skeletal muscles during exercise and recovery.

CFS simulations exhibit critically low levels of ATP, where an increased rate of cell death would be expected. To stabilize the energy supply at low ATP concentrations the total adenine nucleotide pool is reduced substantially causing a prolonged recovery time even without consideration of other factors, such as immunological dysregulations and oxidative stress.

Repeated exercises worsen this situation considerably. Furthermore, CFS simulations exhibited an increased acidosis and lactate accumulation consistent with experimental observations.

Highlights

  • Metabolite dynamics in skeletal muscles are simulated during high intensity exercise.
  • We take into account exercise induced purine nucleotide loss and de novo synthesis.
  • A reduced mitochondrial capacity is assumed for CFS patients.
  • CFS simulations exhibit critically low levels of ATP and a prolonged recovery time.
  • Additionally an increased acidosis and lactate accumulation is observed in CFS.

In silico analysis of exercise intolerance in myalgic encephalomyelitis/chronic fatigue syndrome, by Nicor Lengert & Barbara Drossel in Biophysical Chemistry, 4 April 2015 [e-publication before print].

Posted in News | Tagged , , , , | Comments Off on Computer simulation explores cause for exercise intolerance in ME/CFS

Inflammatory hypothesis of mood spectrum

Review abstract

OBJECTIVES:

The present paper aimed at reviewing literature data on the inflammatory hypothesis of mood spectrum, as well as the overlapping features with some chronic rheumatologic disorders, in particular fibromyalgia and chronic fatigue syndrome.

METHODS:

A literature search was carried out for English papers published in the years 2000-2014, while using the following words: mood spectrum, depression, bipolar disorders, fibromyalgia, chronic fatigue syndrome, neurotransmitters, inflammation, neuroinflammation, cytokines.

RESULTS:

Overlapping features were highlighted between mood spectrum, fibromyalgia and chronic fatigue syndrome suggesting common underlying mechanisms at pathophysiological level involving both central nervous and the immune systems.

CONCLUSIONS:

Taken together, the literature would suggest that the borders between different medical domains should be reconsidered in the light of common processes linking them.

The inflammatory hypothesis of mood spectrum broadened to fibromyalgia and chronic fatigue syndrome, by Dell’Osso L, Bazzichi L, Baroni S, Falaschi V, Conversano C, Carmassi C, Marazziti D in Clin Exp Rheumatol. 2015 Mar-Apr;33 Suppl 88(1):109-116. Epub 2015 Mar 18

 

Posted in News | Tagged , , , | Comments Off on Inflammatory hypothesis of mood spectrum

Autoimmune/inflammatory syndrome induced by adjuvants

Research abstract:

In 1964, Miyoshi reported a series of patients with diverse symptoms after receiving treatment with silicone or paraffin fillers. Miyoshi named this condition ‘human adjuvant disease’. Since then, the literature has been flooded with case reports and case series of granulomatous and systemic autoimmune disorders related to vaccines, infection or other adjuvants such as silicone and other biomaterials.

A new term – autoimmune/inflammatory syndrome induced by adjuvants – has recently been coined for a process that includes several clinical features previously described by Miyoshi plus other clinical and laboratory parameters related to exposure to diverse external stimuli.

Disorders such as siliconosis, Gulf War syndrome, macrophagic myofasciitis syndrome, sick building syndrome and post-vaccination syndrome have been included in autoimmune/inflammatory syndrome induced by adjuvants. Disorders such as Spanish toxic oil syndrome and Ardystil syndrome could also be included.

Furthermore, biomaterials other than silicone should also be considered as triggering factors for these adjuvant-related syndromes. New diagnostic criteria in this field have been proposed. Nevertheless, many of these criteria are too subjective, leading to some patients being diagnosed with chronic fatigue syndrome or other ‘central sensitization syndromes’.

Diagnostic criteria based only on objective clinical and laboratory data to be further discussed and validated are proposed herein.

Human adjuvant-related syndrome or autoimmune/inflammatory syndrome induced by adjuvants. Where have we come from? Where are we going? A proposal for new diagnostic criteria, by J Alijotas-Reig in Lupus. 2015 Mar 25.  [Epub ahead of print]

Posted in News | Tagged , , , | Comments Off on Autoimmune/inflammatory syndrome induced by adjuvants

Review of exercise therapy studies

Review abstract

BACKGROUND:

Chronic fatigue syndrome (CFS) is characterised by persistent, medically unexplained fatigue, as well as symptoms such as musculoskeletal pain, sleep disturbance, headaches and impaired concentration and short-term memory. CFS presents as a common, debilitating and serious health problem. Treatment may include physical interventions, such as exercise therapy, which was last reviewed in 2004.

OBJECTIVES

The objective of this review was to determine the effects of exercise therapy (ET) for patients with CFS as compared with any other intervention or control.

  • Exercise therapy versus ‘passive control’ (e.g. treatment as usual, waiting-list control, relaxation, flexibility).
  • Exercise therapy versus other active treatment (e.g. cognitive-behavioural therapy (CBT), cognitive treatment, supportive therapy, pacing, pharmacological therapy such as antidepressants).
  • Exercise therapy in combination with other specified treatment strategies versus other specified treatment strategies (e.g. exercise combined with pharmacological treatment vs pharmacological treatment alone).

SEARCH METHODS

We searched The Cochrane Collaboration Depression, Anxiety and Neurosis Controlled Trials Register (CCDANCTR), the Cochrane Central Register of Controlled Trials (CENTRAL) and SPORTDiscus up to May 2014 using a comprehensive list of free-text terms for CFS and exercise. We located unpublished or ongoing trials through the World Health Organization (WHO) International Clinical Trials Registry Platform (to May 2014). We screened reference lists of retrieved articles and contacted experts in the field for additional studies

SELECTION CRITERIA

Randomised controlled trials involving adults with a primary diagnosis of CFS who were able to participate in exercise therapy. Studies had to compare exercise therapy with passive control, psychological therapies, adaptive pacing therapy or pharmacological therapy.

DATA COLLECTION AND ANALYSIS

Two review authors independently performed study selection, risk of bias assessments and data extraction. We combined continuous measures of outcomes using mean differences (MDs) and standardised mean differences (SMDs). We combined serious adverse reactions and drop-outs using risk ratios (RRs). We calculated an overall effect size with 95% confidence intervals (CIs) for each outcome.

MAIN RESULTS

We have included eight randomised controlled studies and have reported data from 1518 participants in this review. Three studies diagnosed individuals with CFS using the 1994 criteria of the Centers for Disease Control and Prevention (CDC); five used the Oxford criteria. Exercise therapy lasted from 12 to 26 weeks.

Seven studies used variations of aerobic exercise therapy such as walking, swimming, cycling or dancing provided at mixed levels in terms of intensity of the aerobic exercise from very low to quite rigorous, whilst one study used anaerobic exercise. Control groups consisted of passive control (eight studies; e.g. treatment as usual, relaxation, flexibility) or CBT (two studies), cognitive therapy (one study), supportive listening (one study), pacing (one study), pharmacological treatment (one study) and combination treatment (one study). Risk of bias varied across studies, but within each study, little variation was found in the risk of bias across our primary and secondary outcome measures.

Investigators compared exercise therapy with ‘passive’ control in eight trials, which enrolled 971 participants. Seven studies consistently showed a reduction in fatigue following exercise therapy at end of treatment, even though the fatigue scales used different scoring systems: an 11-item scale with a scoring system of 0 to 11 points (MD -6.06, 95% CI -6.95 to -5.17; one study, 148 participants; low-quality evidence); the same 11-item scale with a scoring system of 0 to 33 points (MD -2.82, 95% CI -4.07 to -1.57; three studies, 540 participants; moderate-quality evidence); and a 14-item scale with a scoring system of 0 to 42 points (MD -6.80, 95% CI -10.31 to -3.28; three studies, 152 participants; moderate-quality evidence). Serious adverse reactions were rare in both groups (RR 0.99, 95% CI 0.14 to 6.97; one study, 319 participants; moderate-quality evidence), but sparse data made it impossible for review authors to draw conclusions. Study authors reported a positive effect of exercise therapy at end of treatment with respect to sleep (MD -1.49, 95% CI -2.95 to -0.02; two studies, 323 participants), physical functioning (MD 13.10, 95% CI 1.98 to 24.22; five studies, 725 participants) and self-perceived changes in overall health (RR 1.83, 95% CI 1.39 to 2.40; four studies, 489 participants). It was not possible for review authors to draw conclusions regarding the remaining outcomes.

Investigators compared exercise therapy with CBT in two trials (351 participants). One trial (298 participants) reported little or no difference in fatigue at end of treatment between the two groups using an 11-item scale with a scoring system of 0 to 33 points (MD 0.20, 95% CI -1.49 to 1.89). Both studies measured differences in fatigue at follow-up, but neither found differences between the two groups using an 11-item fatigue scale with a scoring system of 0 to 33 points (MD 0.30, 95% CI -1.45 to 2.05) and a nine-item Fatigue Severity Scale with a scoring system of 1 to 7 points (MD 0.40, 95% CI -0.34 to 1.14). Serious adverse reactions were rare in both groups (RR 0.67, 95% CI 0.11 to 3.96). We observed little or no difference in physical functioning, depression, anxiety and sleep, and we were not able to draw any conclusions with regard to pain, self-perceived changes in overall health, use of health service resources and drop-out rate.

With regard to other comparisons, one study (320 participants) suggested a general benefit of exercise over adaptive pacing, and another study (183 participants) a benefit of exercise over supportive listening. The available evidence was too sparse to draw conclusions about the effect of pharmaceutical interventions.

AUTHORS’ CONCLUSIONS

Patients with CFS may generally benefit and feel less fatigued following exercise therapy, and no evidence suggests that exercise therapy may worsen outcomes. A positive effect with respect to sleep, physical function and self-perceived general health has been observed, but no conclusions for the outcomes of pain, quality of life, anxiety, depression, drop-out rate and health service resources were possible.

The effectiveness of exercise therapy seems greater than that of pacing but similar to that of CBT. Randomised trials with low risk of bias are needed to investigate the type, duration and intensity of the most beneficial exercise intervention.

Intervention Review: Exercise therapy for chronic fatigue syndrome, by Lillebeth Larun, Kjetil G. Brurberg, Jan Odgaard-Jensen, Jonathan R Price in Cochrane Database Syst Rev. 2015 Feb 10; 2:CD003200

Posted in News | Tagged , , | Comments Off on Review of exercise therapy studies

Immune biomarkers discussion

A team of American scientists discuss Prof Mady Hornig’s recent research on immune signatures in ME/CFS. They review identification of immune biomarkers in CFS/ME patients, and how a cell nuclease controls the innate immune response to vaccinia virus infection. [Introductions last about 8 minutes]

TWiV 329: Pox in the balance, March 22, 2015

Hosts: Vincent Racaniello, Dickson Despommier, Alan Dove, Rich Condit, and Kathy Spindler

Posted in News | Comments Off on Immune biomarkers discussion

Appropriate management of FM & CFS can give moderate improvements

Research abstract:

Fibromyalgia and chronic fatigue syndrome represent two of the most commonly encountered functional somatic syndromes in clinical practice. Both have been contentious diagnoses in the past, and this diagnostic dispute has resulted in a therapeutic nihilism that has been of great detriment to their management and to alleviation of the intense suffering and disability that they have caused their innumerable sufferers.

A new age has dawned in terms of a better understanding of these syndromes’ physiology and improved approaches to their management. Here, the diagnosis and management of these closely related disorders are discussed, with particular reference to the recent empirical evidence that has come to light as a consequence of neurophysiological insights and robustly designed randomised clinical trials.

Much work remains to be done in this vein, but we are better placed to facilitate recovery from these disorders than we have been previously. Whilst remission should always be a goal, complete symptom resolution is not the norm, but ‘moderate’ improvements are certainly attainable with appropriate management.

Fibromyalgia and Chronic Fatigue Syndrome: Management Issues, by J Bourke J. in Adv Psychosom Med. 2015;34:78-91.  Epub 2015 Mar 30.

Posted in News | Tagged , , , | Comments Off on Appropriate management of FM & CFS can give moderate improvements

Sleep/wake behaviour in ME/CFS

Research abstract:

Sleep dysfunction is a prominent feature in the subjective experience of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS).

Although studies using polysomonography have identified at least one abnormal sleep characteristic in individuals with ME/CFS, no standard abnormalities in sleep have been identified. At the time of writing, only one published study had compared actigraphic measures of sleep between ME/CFS and controls, with no differences found. The aim of this study was to compare sleep parameters in people with and without ME/CFS using self-report and actigraphy.

The sample consisted of 16 individuals with ME/CFS and 16 healthy controls matched for age and sex who were self-reported good sleepers. Participants wore a wrist actiwatch and kept a sleep diary for 7 days. Participants were asked to give subjective ratings sleep quality and feeling rested each morning.

Results showed that individuals with ME/CFS experienced objectively (as measured by actigraphy) longer sleep onset latency and duration of wake after sleep onset, more fragmented sleep, and lower sleep efficiency than controls, with no difference in total sleep time. They also reported longer subjective (as reported in sleep diaries) sleep onset latency and duration of wake after sleep onset, and lower sleep efficiency, with no difference in total sleep time.

The ME/CFS group also reported poorer sleep quality and feeling less rested after
sleep. Individuals with ME/CFS experienced greater variability over the seven day assessment period in objective (actigraphic) total sleep time, sleep efficiency and duration of wake after sleep onset, and greater variability of subjective sleep efficiency and feeling rested than controls.

These results provide objective evidence to support the subjective reports of poor sleep in ME/CFS and suggest possible bases of the nonrestorative sleep described in ME/CFS. From a clinical perspective this highlights the importance of including sleep assessment and the treatment of sleep problems in this population as part of a holistic management plan.

The original intention of this study was to include cardiopulmonary coupling (CPC) as an additional measure in the investigation of possible differences between the sleep of ME/CFS and control groups. However, technical difficulties with the SleepImage M1™ devices lead to CPC data only being available from a subgroup of participants, which included both ME/CFS and control participants.

The available CPC data (n = 17) offered an opportunity to assess the validity of the M1™ device against actigraphic and subjective assessments. Analyses found mainly weak and non-significant correlations between CPC measures and the other measures of sleep quality. Total sleep time as measured by CPC was also significantly greater than actigraphic sleep time. Further research is needed before the M1™ device may be considered a valid measure of sleep quality

Investigation of naturalistic sleep/wake behaviour in myalgic encephaloyelitis/chronic fatigue syndrome, by Catherine Stevens, Victoria University thesis, March 4, 2015

Posted in News | Tagged , , | Comments Off on Sleep/wake behaviour in ME/CFS

Why exercise magnifies exhaustion in CFS

Study shows why exercise magnifies exhaustion for chronic fatigue syndrome patients [March 12 2015]

The mechanism that causes high-performance athletes to “feel the burn”
turns out to be the culprit in what makes people with chronic fatigue syndrome feel exhausted by the most common daily activities, new University of Florida Health research shows.

Published in the February issue of the journal Pain, the study shows that the neural pathways that transmit feelings of fatigue to the brain might be to blame. In those with chronic fatigue syndrome, the pathways do their job too well.

The findings also provide evidence for the first time that peripheral tissues such as muscles contribute to feelings of fatigue. Determining the origins of fatigue could help researchers develop therapies or identify targets for those therapies.

Researchers focused on the role of muscle metabolites, including lactic acid and adenosine triphosphate, or ATP, in the disease. The study has demonstrated for the first time that these substances, released when a person exercises his or her muscles, seem to activate these neural pathways. Also, UF Health researchers have shown that these pathways seem to be much more sensitive in patients with chronic fatigue syndrome than in patients without the disease, something that hasn’t been studied before.

Chronic fatigue syndrome, which the Institute of Medicine recently renamed systemic exertion intolerance disease, or SEID, is characterized by extreme chronic fatigue. Because its chief symptom — fatigue — is often associated with many other diseases, it can be difficult to diagnose SEID for the more than 1 million people who actually have the disease, according to the Centers for Disease Control and Prevention. The disease has no root medical cause, and researchers don’t know what triggers it. But they are studying aspects of the disease to figure out ways to treat it.

“What we have shown now, that has never been shown before in humans, is that muscle metabolites can induce fatigue in healthy people as well as patients who already have fatigue,” said Dr. Roland Staud, a professor of rheumatology and clinical immunology in the UF College of Medicine and the paper’s lead author.

During exercise, muscles produce metabolites, which are sensed by metaboreceptors that transmit information via fatigue pathways to the brain, according to the researchers. But in patients with SEID, these fatigue pathways have become highly sensitive to metabolites and can trigger excessive feelings of fatigue.

“For most of us, at the end of strenuous exertion we feel exhausted and need to stop — but we will recover rapidly,” Staud said. “However, these individuals tire much more rapidly and sometimes just after moving across a room, they are fully exhausted. This takes a toll on their lives.”

Staud and co-author Michael E. Robinson, a professor in the department of clinical and health psychology in the UF College of Public Health and Health Professions, recruited a group of 39 patients with SEID and 29 participants without the disease. The researchers asked the participants to don a blood pressure cuff just above their elbows on their dominant side, pick up a spring-loaded device and squeeze it to
100 percent of their maximum capacity, which was measured by a dial.

With research assistants encouraging them, the study participants then squeezed the device so that the dial showed they were gripping at 50 percent of their maximum capacity for as long as they could.

At the end of the hand-grip exercise, the blood pressure cuff on the participant’s arm was inflated, almost instantly trapping the metabolites generated by the exercise within the forearm muscles. This allowed the metabolites to collect in the forearm tissue without being cleared by the circulatory system. There, the metabolites continued to activate fatigue pathways, sending messages of fatigue to the brain and allowing researchers to measure how much fatigue and pain may occur because of the trapped metabolites.

With the blood pressure cuff still inflated, the participants rated fatigue and then pain in their forearms every 30 seconds. Both patients with SEID and patients without the disease reported increasing fatigue, but patients with the disease recorded much higher levels of fatigue and pain.

“We found that the fatigued individuals reported more fatigue than the non-fatigued individuals during the exercise, and also found that they had more pain compared to the non-fatigued individuals,” Staud said.

On the Fatigue Visual Analog Scale used to measure participants’ fatigue, patients with SEID rated their fatigue at approximately 5.5 on a scale of 0 to 10 after the hand-grip exercise while wearing the inflated blood pressure cuff, whereas participants without the disease rated their fatigue at approximately 1.5.

After 30 minutes, the participants repeated the exercise, but with the opposite arm and without the cinching blood pressure cuff so the metabolites could be cleared from the arm. Both sets of participants experienced fatigue, but the feeling of fatigue in those with the disease was much lower than when the metabolites were trapped with the blood pressure cuff.

“This suggests that hypersensitive fatigue pathways play an important role for the often pronounced exercise-related fatigue of patients with the disease,” Staud said.

Next, Staud plans to explore treatment interventions and to conduct brain-imaging studies of patients with SEID.

“The take-home message here is, like many of the pain studies we have conducted, there are both peripheral and central nervous system factors at play in these complex syndromes,” said Robinson, who is also the director of the UF Center for Pain Research and Behavioral Health. “Our study seems to highlight the important role of these peripheral tissues.”

 

Posted in News | Tagged , | Comments Off on Why exercise magnifies exhaustion in CFS

The many roads to mitochondrial dysfunction in neuroimmune and neuropsychiatric disorders

Article abstract

Background:
Mitochondrial dysfunction and defects in oxidative metabolism are a characteristic feature of many chronic illnesses not currently classified as mitochondrial diseases. Examples of such illnesses include bipolar disorder, multiple sclerosis, Parkinson’s disease, schizophrenia, depression, autism, and chronic fatigue syndrome.

Discussion:
While the majority of patients with multiple sclerosis appear to have widespread mitochondrial dysfunction and impaired ATP production, the findings in patients diagnosed with Parkinson’s disease, autism, depression, bipolar disorder schizophrenia and chronic fatigue syndrome are less consistent, likely reflecting the fact that these diagnoses do not represent a disease with a unitary pathogenesis and pathophysiology. However, investigations have revealed the presence of chronic oxidative stress to be an almost invariant finding in study cohorts of patients afforded each diagnosis. This state is characterized by elevated reactive oxygen and nitrogen species and/or reduced levels of glutathione, and goes hand in hand with chronic systemic inflammation with elevated levels of pro-inflammatory cytokines.

Summary:
This paper details mechanisms by which elevated levels of reactive oxygen and nitrogen species together with elevated pro-inflammatory cytokines could conspire to pave a major road to the development of mitochondrial dysfunction and impaired oxidative metabolism seen in many patients diagnosed with these disorders.

The many roads to mitochondrial dysfunction in neuroimmune and neuropsychiatric disorders, by  Gerwyn Morris and Michael Berk, in BMC Medicine 2015, 13:68

Posted in News | Tagged , | Comments Off on The many roads to mitochondrial dysfunction in neuroimmune and neuropsychiatric disorders